vs

Side-by-side financial comparison of Alight, Inc. (ALIT) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

Alight, Inc. is the larger business by last-quarter revenue ($653.0M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -142.7%, a 132.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -4.0%). Alight, Inc. produced more free cash flow last quarter ($99.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 8.1%).

Alight Solutions is an American information technology and consulting company that provides cloud-based systems, outsourcing and consultancy related to human resource. They provide platforms and outsourcing for large companies to manage their human capital this includes health benefit administration, financial management and retirement planning.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

ALIT vs CLOV — Head-to-Head

Bigger by revenue
ALIT
ALIT
1.3× larger
ALIT
$653.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+48.7% gap
CLOV
44.7%
-4.0%
ALIT
Higher net margin
CLOV
CLOV
132.6% more per $
CLOV
-10.1%
-142.7%
ALIT
More free cash flow
ALIT
ALIT
$168.0M more FCF
ALIT
$99.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
8.1%
ALIT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALIT
ALIT
CLOV
CLOV
Revenue
$653.0M
$487.7M
Net Profit
$-932.0M
$-49.3M
Gross Margin
36.8%
Operating Margin
-114.9%
-10.1%
Net Margin
-142.7%
-10.1%
Revenue YoY
-4.0%
44.7%
Net Profit YoY
-11750.0%
-123.2%
EPS (diluted)
$-1.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALIT
ALIT
CLOV
CLOV
Q4 25
$653.0M
$487.7M
Q3 25
$533.0M
$496.6M
Q2 25
$528.0M
$477.6M
Q1 25
$548.0M
$462.3M
Q4 24
$680.0M
$337.0M
Q3 24
$555.0M
$331.0M
Q2 24
$538.0M
$356.3M
Q1 24
$559.0M
$346.9M
Net Profit
ALIT
ALIT
CLOV
CLOV
Q4 25
$-932.0M
$-49.3M
Q3 25
$-1.1B
$-24.4M
Q2 25
$-1.1B
$-10.6M
Q1 25
$-25.0M
$-1.3M
Q4 24
$8.0M
$-22.1M
Q3 24
$-74.0M
$-9.2M
Q2 24
$23.0M
$7.4M
Q1 24
$-114.0M
$-19.2M
Gross Margin
ALIT
ALIT
CLOV
CLOV
Q4 25
36.8%
Q3 25
33.4%
Q2 25
33.3%
Q1 25
31.2%
Q4 24
39.9%
Q3 24
31.4%
24.5%
Q2 24
31.0%
30.3%
Q1 24
32.6%
23.6%
Operating Margin
ALIT
ALIT
CLOV
CLOV
Q4 25
-114.9%
-10.1%
Q3 25
-248.0%
-4.9%
Q2 25
-191.3%
-2.2%
Q1 25
-1.5%
-0.3%
Q4 24
6.5%
-6.4%
Q3 24
-7.6%
-2.7%
Q2 24
-9.7%
2.0%
Q1 24
-7.2%
-6.5%
Net Margin
ALIT
ALIT
CLOV
CLOV
Q4 25
-142.7%
-10.1%
Q3 25
-200.2%
-4.9%
Q2 25
-203.2%
-2.2%
Q1 25
-4.6%
-0.3%
Q4 24
1.2%
-6.6%
Q3 24
-13.3%
-2.8%
Q2 24
4.3%
2.1%
Q1 24
-20.4%
-5.5%
EPS (diluted)
ALIT
ALIT
CLOV
CLOV
Q4 25
$-1.77
Q3 25
$-2.02
Q2 25
$-2.03
Q1 25
$-0.05
Q4 24
$0.02
Q3 24
$-0.14
Q2 24
$0.04
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALIT
ALIT
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$273.0M
$78.3M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$1.0B
$308.7M
Total Assets
$4.6B
$541.0M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALIT
ALIT
CLOV
CLOV
Q4 25
$273.0M
$78.3M
Q3 25
$205.0M
Q2 25
$227.0M
Q1 25
$223.0M
Q4 24
$343.0M
$194.5M
Q3 24
$300.0M
$288.0M
Q2 24
$183.0M
$254.8M
Q1 24
$256.0M
$208.3M
Total Debt
ALIT
ALIT
CLOV
CLOV
Q4 25
$2.0B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.8B
Q1 24
$2.8B
Stockholders' Equity
ALIT
ALIT
CLOV
CLOV
Q4 25
$1.0B
$308.7M
Q3 25
$2.0B
$340.9M
Q2 25
$3.1B
$344.2M
Q1 25
$4.2B
$336.1M
Q4 24
$4.3B
$341.1M
Q3 24
$4.3B
$342.2M
Q2 24
$4.5B
$324.9M
Q1 24
$4.5B
$292.5M
Total Assets
ALIT
ALIT
CLOV
CLOV
Q4 25
$4.6B
$541.0M
Q3 25
$5.5B
$559.7M
Q2 25
$6.8B
$575.0M
Q1 25
$7.9B
$583.7M
Q4 24
$8.2B
$580.7M
Q3 24
$8.3B
$653.0M
Q2 24
$10.5B
$674.2M
Q1 24
$10.7B
$671.8M
Debt / Equity
ALIT
ALIT
CLOV
CLOV
Q4 25
1.92×
Q3 25
1.00×
Q2 25
0.65×
Q1 25
0.48×
Q4 24
0.47×
Q3 24
0.47×
Q2 24
0.62×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALIT
ALIT
CLOV
CLOV
Operating Cash FlowLast quarter
$124.0M
$-66.9M
Free Cash FlowOCF − Capex
$99.0M
$-69.0M
FCF MarginFCF / Revenue
15.2%
-14.1%
Capex IntensityCapex / Revenue
3.8%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$250.0M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALIT
ALIT
CLOV
CLOV
Q4 25
$124.0M
$-66.9M
Q3 25
$77.0M
$12.1M
Q2 25
$86.0M
$5.4M
Q1 25
$73.0M
$-16.3M
Q4 24
$118.0M
$34.8M
Q3 24
$-24.0M
$50.0M
Q2 24
$58.0M
$44.8M
Q1 24
$100.0M
$25.9M
Free Cash Flow
ALIT
ALIT
CLOV
CLOV
Q4 25
$99.0M
$-69.0M
Q3 25
$49.0M
$11.4M
Q2 25
$58.0M
$4.8M
Q1 25
$44.0M
$-16.5M
Q4 24
$92.0M
$33.3M
Q3 24
$-52.0M
$49.6M
Q2 24
$22.0M
$44.4M
Q1 24
$69.0M
$25.5M
FCF Margin
ALIT
ALIT
CLOV
CLOV
Q4 25
15.2%
-14.1%
Q3 25
9.2%
2.3%
Q2 25
11.0%
1.0%
Q1 25
8.0%
-3.6%
Q4 24
13.5%
9.9%
Q3 24
-9.4%
15.0%
Q2 24
4.1%
12.5%
Q1 24
12.3%
7.3%
Capex Intensity
ALIT
ALIT
CLOV
CLOV
Q4 25
3.8%
0.4%
Q3 25
5.3%
0.1%
Q2 25
5.3%
0.1%
Q1 25
5.3%
0.0%
Q4 24
3.8%
0.5%
Q3 24
5.0%
0.1%
Q2 24
6.7%
0.1%
Q1 24
5.5%
0.1%
Cash Conversion
ALIT
ALIT
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
14.75×
Q3 24
Q2 24
2.52×
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALIT
ALIT

Recurring$607.0M93%
Projects$46.0M7%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons